Mark Oette

High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran

Leishmaniasis

TT Viruses: Oncogenic or Tumor-Suppressive Properties?

The MEME Suite

Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir

Oral multispecies biofilm development and the key role of cell–cell distance

Molecular assays for monitoring HIV infection and antiretroviral therapy

The disclosure processes model: Understanding disclosure decision making and postdisclosure outcomes among people living with a concealable stigmatized identity.

Viral Population Estimation Using Pyrosequencing

Skeletal infections: microbial pathogenesis, immunity and clinical management

Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries

The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence

Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders

PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Update on ocular syphilis

Expert opinion on the treatment of patients with chronic hepatitis C

Vertebral Osteomyelitis

Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

Antiretroviral Treatment of Adult HIV Infection

Is periodontal disease a risk factor for severe COVID-19 illness?

SARS-CoV-2 in wastewater: State of the knowledge and research needs

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

UK national guidelines on the management of syphilis 2015

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals

Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution

Oral mucosal fungal infections

Preclinical models of vertebral osteomyelitis and associated infections: Current models and recommendations for study design

Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype

Point-of-Care Diagnostics for Global Health

Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

Viral Quasispecies Evolution

Towards a small animal model for hepatitis C

Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment

Methods for optimizing antiviral combination therapies

Guidelines for the management of hemophilia

Lipodystrophy Syndrome and Self-Assessment of Well-Being and Physical Appearance in HIV-Positive Patients

Case Report: Acute Syphilitic Blindness in an HIV-Positive Patient

Treatment of Spondylodiscitis in Human Immunodeficiency Virus-Infected Patients

Trends of prevalence of primary HIV drug resistance in Germany

Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance Testing

Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure

Visceral Leishmaniasis Presenting as Subcutaneous Nodules in a HIV-Positive Patient

SEN virus has an adverse effect on the survival of HIV-positive patients

Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients

SEN virus seroprevalence in HIV positive patients: association with immunosuppression and HIV-replication

Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection

Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals

Risk Factors Associated with Older Age in Treatment-Naive HIV-Positive Patients

Computational methods for the design of effective therapies against drug resistant HIV strains

Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette Guerin (BCG) in an HIV-positive child

Compensatory Mutations at the HIV Cleavage Sites P7/P1 and P1/P6-Gag in Therapy-Naive and Therapy-Experienced Patients

Geno2pheno is predictive of short-term virological response

Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.